Languages Available
English - 中文 - 日本語
 
C

PT. Indofarma (Persero) Tbk [INAF]   Rp. 2.920  0 (0%)


Loading...
INAF Rp. 2.920  0 (0%)
Last Update 29 June 2017 04:00 PM
Open
Rp. 2,920
Prev Close
Rp. 2,920
Offer
Rp. 2,930
Bid
Rp. 2,920
Day Low
Rp. 2,920
Day High
Rp. 2,970
Volume
3,059 Lots (305,900 Shares)
Value
900.33 M
Frequency
241
EPS
-5.6
PE Ratio (ttm)
-521.11
Market Cap.
9,049,080.00 M
Market Cap. Rank in Industry
#3 of 11 Companies in Pharmaceuticals
Market Cap. Rank in All Companies
#98 of 568 Companies
F
Net Foreign

This section of IDNFinancials requires you to sign up as a premium member of IDNFinancials.

Please check our pricing page to see all of our features.
O
Overview


PT. Indofarma (Persero) Tbk (INAF) is a manufacturer of drug, which consists of several product categories, namely Unbranded Generic or OTC Over the Counter (OTC), branded generic, rapid diagnostic test, and others. In addition, it also produces packaging materials, machinery, equipment and infrastructure related to pharmaceutical and other industries. The company commenced its commercial operations and production on 1983. The company’s products are marketed both domestically and internationally.

 

Source: www.indofarma.co.id

Subsidiary Affiliation
 
Company
Percentage
1.
PT. Indofarma Global Medika
99.99 %
G
Management
Commissioners
-
President Commissioner
Commissioner
Independent Commissioner
Teddy Wibisana
Directors
-
President Director
Rusdi Rosman
Director
Director
Wahyuli Syafari
Graph goes here...
S
Shareholders
No. Shareholder Name Number of Shares Total Paidup Capital Percentage
1. (Serie B) - Pemerintah Republik Indonesia 2,499,999,999 249,999,999,900 (IDR) 80.66 %
2. (Serie B) - Public (each below 5%) 399,271,000 39,927,100,000 (IDR) 12.00 %
3. (Serie B) - PT. Asabri 199,996,500 19,999,650,000 (IDR) 6.00 %
4. (Serie A) - Public (each below 5%) 1 100 (IDR) 0.00000000 %
V
Videos
IDNFinancials Video - Company profile PT Indofarma Tbk
10 January 2013 09:02 AM
Company profile PT Indofarma Tbk
S
News Update
10 August 2015 11:04 AM Indofarma Targets 15-20% Margin Growth yosefardi.biz
09 September 2015 04:43 PM Siti Fadilah testifies medical equipments case trial yosefardi.biz
A
Announcement
Indofarma (Persero) will hold annual shareholders' meeting on April 20, 2017
2017-03-10 11:00:02
Links: [1]
Indofarma will hold annual shareholders' meeting on April 6, 2016
2016-02-22 23:05:27
Links: [1] [2]
S
Financial
Period Revenue Net Profit
Q3 - 2016 397,308 M -2,542 M
Q2 - 2016 269,820 M -8,291 M
Q1 - 2016 201,499 M -19,574 M
Q4 - 2015 826,476 M 38,539 M
Q3 - 2015 332,643 M -8,168 M
Q2 - 2015 268,051 M -3,861 M
Q1 - 2015 194,728 M -19,944 M
Q4 - 2014 588,600 M 36,837 M
Full financial and operational data available to our premium users. Please check our premium data introduction page to learn more about our tools.
11 September 2014 10:20 AM
03 March 2014 09:02 AM
24 December 2013 08:38 AM
19 March 2013 09:57 AM
20 February 2013 03:56 PM
20 February 2013 03:52 PM
20 February 2013 03:50 PM